Broadening the targets of treatment to include diminished use or other clinically significant outcomes for a principal outcome for medication approval could potentially increase therapeutic interventions and support boost the volume of persons in treatment. It could also decrease the stigma that is often associated with return to use. Stack https://g.page/r/CfWLpCm6L55SEBM